We report here the laboratory investigation of the first known case of botulism in the United States caused by Clostridium butyricum type E. This investigation demonstrates the importance of extensive microbiological examination of specimens, which resulted in the isolation of this organism. B otulism is a rare but acute paralytic disease caused by botulinum neurotoxin (BoNT). Botulism can occur when contaminated food is ingested (food-borne) or when BoNT-producing clostridia colonize wounds or the intestine. Infant botulism occurs through intestinal colonization by BoNT-producing clostridia and the subsequent in situ production of BoNT in infants (1). Diagnosis is based on clinical presentation (1, 2). In the United States, botulism immune globulin human (intravenous) (BIG-IV) is available for the treatment of infant botulism through the California Department of Public Heath (CDPH) Infant Botulism Treatment and Prevention Program (IBTPP) (2). Laboratory confirmation is performed at the Centers for Disease Control and Prevention (CDC) and state public health laboratories (1, 2).
tory testing. The sample was tested for BoNT by mouse bioassay (1) . Procedures were conducted in accordance with Association for Assessment and Accreditation of Laboratory Animal Care guidelines and institutionally approved protocols for the ethical use of laboratory animals. The amount of BoNT type E detected in the stool was 126,400 mLD 50 /g (mLD 50 , 50% mouse lethal dose), which is Ͼ150 times higher than that previously reported for type E infant botulism cases (4) . The stool sample was cultured for the growth of BoNT-producing clostridia using standard laboratory methods (9) . McClung-Toabe egg yolk agar (EYA) plates were streaked for isolation from stool and from enriched broth cultures. Plates were incubated for 2 to 3 days, and broth cultures C. tertium is an aerotolerant anaerobe common in the fecal flora of infants (10, 11) that can be readily distinguished from the obligate anaerobe C. butyricum by growth under aerobic conditions. Further, C. tertium produces oval terminal spores, whereas C. butyricum produces subterminal spores (10) . Out of the 25 Lip Ϫ /Lec Ϫ isolates examined, 23 isolates showed growth on blood agar under aerobic conditions and/or terminal spores by Gram stain, suggesting that the majority of these isolates were C. tertium. Direct stool and enrichment cultures were heat shocked (80°C for 15 min.) and treated with alcohol (equal parts sample and 100% ethanol for 1 h) to eliminate vegetative growth and select for clostridia. However, these methods were not useful in eliminating these associated nontoxic bacteria from the stool culture.
Strain CDC51208 was characterized by molecular analysis. The bont/E gene nucleotide sequence was determined using previously reported primers that amplified overlapping regions of the gene (12) and was submitted to GenBank under accession number KP455988. Of the 11 currently recognized bont/E subtypes, only E4 and E5 are known to be produced by C. butyricum (13) . The nucleotide sequence of bont/E in strain CDC51208 clustered with other bont/E4 sequences (Fig. 1) . All previously reported strains containing bont/E4 are associated with botulism cases in Italy. C. butyricum strains containing bont/E5 are associated with a foodborne outbreak and soil samples from China (12) . C. butyricum strain CDC51208 was compared by pulsed-field gel electrophoresis (PFGE) (14) to two available C. butyricum type E strains, 5262 and 5520, from the first and second Italian infant botulism cases, respectively (3). Although the bont/E sequences of strains 5262, 5520, and CDC51208 were identical, the SmaI and XhoI PFGE profiles of strains 5262 and 5520 (Ͼ93% similar to each other) were distinct from that of CDC51208 (Ͻ66% similar) ( Fig. 2A) . These results indicate that while the toxin gene sequence is stable among the strains examined, differences in the genomic background of these strains appear to be associated with their origin (i.e., CDC51208, which was isolated in the United States, was genetically distinct from the Italian strains 5520 and 5262).
Identification of antimicrobial resistance genes provided another way to characterize and compare strain CDC51208 to C. butyricum type E isolates from Italy. The genes for ␤-lactamase (bla), tetracycline resistance [tet(P)], and lincomycin resistance protein (lmrB) were previously identified in C. butyricum type E isolates from Italy (15) . Using primer sequences reported by Franciosa et al. (15), we searched for these three genes by PCR in strain CDC51208, and for comparison, in strains 5262 and 5520. Ampli- with dendrograms constructed by unweighted pair group method using average linkages (UPGMA) analysis. PFGE patterns were compared by the Dice coefficient with a tolerance window of 1.5% and an optimization of 1.5%. (B) PCR products (ϳ400 bp) for bla, tet(P), and lmrB. Products were run on a 1% agarose gel and stained with ethidium bromide. The results for strains 5520 and 5562 are consistent with previous findings by Franciosa et al. (15) . fication for bla and tet(P) was observed in all three C. butyricum type E strains (Fig. 2B) . bla was previously identified in C. butyricum type E clinical isolates from Italy and China but was not found in soil isolates from China (15) . The presence of bla in strain CDC51208 lends additional support for the presence of this gene among clinical isolates. Although lmrB was present in strains 5262 and 5520, it was not detected in strain CDC51208 (Fig. 2B) . Interestingly, this gene also was not detected in any isolates containing bont/E5 isolated in China (15) , suggesting that the presence of lmrB is varied among C. butyricum type E strains.
To our knowledge, this is the first case of botulism caused by C. butyricum type E in the United States and the first identification of a strain outside Italy containing bont/E4. The isolation of C. butyricum type E in the United States suggests that this strain may be more widely distributed than was previously recognized. The presence of numerous nontoxigenic Lip ϩ and Lip Ϫ /Lec ϩ bacteria in this infant stool sample and the rarity of C. butyricum type E significantly complicated the identification of this rarely identified cause of infant botulism. Increased awareness of these concomitant strains in infant stool may help investigators more readily identify C. butyricum type E in suspected infant botulism cases.
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